TRxADE Health (NASDAQ: MEDS), a health-services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, is planning to report on its financial results for fourth quarter and year-end 2022 on March 27, 2023. The company noted that the financial results will be made available in a press release after market on that day; the company has also scheduled an earnings conference call and webcast to be held that day at 5:30 p.m. ET. The conference call will be hosted by key TRxADE Health management officials, who will discuss the company’s fourth-quarter and year-end 2022 financial report. The agenda for the event also includes time for a Q&A. Those interested in participating in the conference may dial 1-877-425-9470 (U.S. callers) and 1-201-389-0878 (international callers); participants are encouraged to call in at least 10 minutes before the event is scheduled to begin. The company noted that a replay of the call will be available through April 27, 2023; those interested in hearing the replay may dial 1-844-512-2921 (U.S. callers) or 1-412-317-6671 (international callers) and then enter replay pin number 13737052. In addition, an archived version of the webcast will be available for 30 days on the investment section of the company website.
To view the webcast, visit https://ibn.fm/BM8F9
To view the full press release, visit https://ibn.fm/mESZx
About TRxADE Health Inc
TRxADE Health is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States. The company operates the TRxADE drug procurement marketplace serving more than 14,400 members nationwide, fostering price transparency and, under the Bonum Health brand, offering patient-centric telehealth services. For more information about the company, please visit www.Trxade.com and www.BonumHealth.com.
NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://ibn.fm/MEDS
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.
As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]
InvestorWire is part of the InvestorBrandNetwork